← Back to front page
United States · Platforms & data · Yahoo Finance

Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements

Published by Yahoo Finance · United States 8 h ago
Microbot Medical Inc.
Microbot Medical Inc. · Yahoo Finance

Detailed summary

Company continues to expand commercial presence in the U.S. while it progresses international market entry and opportunities Increased the number of health systems and hospital…

Company continues to expand commercial presence in the U.S. while it progresses international market entry and opportunities

Increased the number of health systems and hospital sites using LIBERTY, while utilization of the LIBERTY System rose 44% compared to the second quarter

HINGHAM, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today announced that it has filed its Quarterly Report on Form 10-Q for the third quarter ended September 30, 2026, with the Securities and Exchange Commission.

The Company reported revenue of $72,000, a sequential decrease compared to revenue of $241,000 during the second quarter ended June 30, 2026. The revenue decrease in Q3 was due to a number of variables including timing of customer re-orders and the seasonality of Q3 (lower activity during summer months). In addition, taking into consideration that the Full Market Release commenced approximately 6 months ago, and that a hospital's Value Analysis Committee (or "VAC") process takes approximately 4-6 months, multiple potential new accounts are still in their VAC process.

The Company reports that 100% of current customers who exhausted their initial inventory have reordered multiple systems, reflecting high customer satisfaction consistent with a Company conducted survey.

During the third quarter, the Company experienced increased procedure utilization within existing accounts.

As anticipated, the Company reported a negative gross margin in the third quarter. Cost of goods sold increased by 24% from the second quarter, largely due to an inventory write-down recognized as a result of measuring inventory at the lower of cost and net realizable value. In addition, under the Company's first-in, first-out (FIFO) inventory method, the cost of systems sold during the quarter primarily reflected units manufactured in earlier periods at higher production costs.

Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading